[Neuroleptics and extrapyramidal effects from the biochemical viewpoint. Discussion by the Workshop on Neuroleptics and the Extrapyramidal System].
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001480:Basal Ganglia Diseases / Q000139:chemically induced / Q000378:metabolism*; D004298:Dopamine / Q000502:physiology; D006801:Humans; D008032:Limbic System / Q000502:physiology; D010276:Parasympatholytics / Q000627:therapeutic use; D011954:Receptors, Dopamine / Q000187:drug effects; D013569:Synapses / Q000378:metabolism
D014150:Antipsychotic Agents; D010276:Parasympatholytics; D011954:Receptors, Dopamine; D004298:Dopamine
Neuroleptika und extrapyramidale Wirkung aus biochemischer Sicht. Diskussionsbeitrag beim Workshop Neuroleptika und extrapyramidales System.